Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1CNS 1

Conditions

Wilms Tumor 1Triple Negative Breast Neoplasms 1Rhabdoid Tumor 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neurofibrosarcoma 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Fallopian Tube Neoplasms 1Castration Levels of Testosterone 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

X-Rays 6Phantoms, Imaging 6Magnetic Resonance Spectroscopy 6Specimen Handling 5Nuclear Medicine Department, Hospital 5Carboplatin 4Biopsy 4tazemetostat 3Mesna 3Melphalan 3Ifosfamide 3Granulocyte Colony-Stimulating Factor 3Etoposide 3Cyclophosphamide 3Busulfan 3ulixertinib 2tipifarnib 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2fludarabine 2etoposide phosphate 2erdafitinib 2ensartinib 2Vemurafenib 2Thiotepa 2Temozolomide 2Stem Cell Transplantation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rhabdoid Tumor × selinexor × Genitourinary × Clear all
NCT05985161 2026-05-06

A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
45 enrolled
GenitourinarySarcoma

Wilms Tumor, Neurofibrosarcoma, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡